Saishi Pharmaceutical (06600): 207,900 share purchase rights have been exercised.
Zhixun Finance APP News, Saiseng Pharmaceutical (06600) released an announcement that on June 7, 2024, 207,900 share purchase rights granted under the first public offering after purchase equity plan have been exercised in accordance with the rules of the first public offering after purchase equity plan.
Saiseng Pharmaceutical (06600): 10,000 stock purchase rights have been exercised.
Zhitong Finance and Economics reported that Saisun Pharmaceutical (06600) announced that on June 5, 2024, 10,000 share purchase rights granted under the first public offering after the stock purchase plan were exercised in accordance with the rules of the first public offering after the stock purchase plan.
Saisun Pharmaceutical: The granted 28,500 share purchase rights have been exercised.
Saisheng Pharmaceutical (06600) announced that on June 4, 2024, 28,500 share purchase rights granted under the first public offering after purchase plan have been exercised in accordance with the rules of the first public offering after purchase plan.
The 10,000 shares options granted by Saisheng Pharmaceutical have expired.
Saisheng Pharmaceutical (06600) announced that on June 3, 2024, 10,000 share purchase rights granted according to the first public offering after-sale share purchase rights plan have expired according to the rules of the plan.
Sai Sheng Pharmaceutical (06600): 10,000 share purchase rights have expired.
Sai Sheng Pharmaceutical (06600) announced that on June 3, 2024, according to the first public offering after the purchase of equity plan...
Saisheng Pharmaceutical (06600): 31,000 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on May 31, 2024, the 31,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical announced that the 28,500 share options granted have been exercised
Saisheng Pharmaceutical (06600) announced that on May 30, 2024, the 28,500 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): 28,500 share options have been exercised
Saisheng Pharmaceutical (06600) issued an announcement. On May 30, 2024, according to the initial public offering after-sales share purchase options...
Saisheng Pharmaceutical (06600.HK): Offeror received a non-binding letter of support from Pentwater for 29.25 million shares
Gelonghui, May 29丨Saisheng Pharmaceutical (06600.HK) issued an announcement. On May 29, 2024, the offender received a non-binding letter of support from Pentwater Capital Management Europe LLP (Pentwater) for 29.25 million shares (approximately 4.64% of the company's issued share capital at the date of this announcement and 8.51% of the issued share capital of the company held by uninterested shareholders, and all shares held by Waterpent on the date of this announcement) , confirming that it will be proposed by the court
Saisheng Pharmaceutical announced that the 390,000 share options granted have been exercised
Saisheng Pharmaceutical (06600) announced that on May 28, 2024, 250,000 share options granted under the share option incentive plan have been exercised in accordance with the rules of the share option incentive plan, and the 140,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): 390,000 share options exercised
Saisheng Pharmaceutical (06600) announced that on May 28, 2024, 250,000 will be awarded under the share purchase incentive plan...
Saisheng Pharmaceutical (06600): A total of 308,000 share options were exercised
Saisheng Pharmaceutical (06600) issued an announcement on May 27, 2024:3... awarded under the share option incentive plan
A total of 71,000 share options announced by Sai Sheng Pharmaceutical have been exercised
Saisheng Pharmaceutical (06600) issued an announcement on May 24, 2024:1. The 6,000 share options granted under the share option incentive plan have been exercised in accordance with the rules of the share option incentive plan; and 2. The 65,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): A total of 71,000 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) issued an announcement on May 24, 2024:1. The 6,000 share options granted under the share option incentive plan have been exercised in accordance with the rules of the share option incentive plan; and 2. The 65,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
Saisheng Pharmaceutical (06600): 135,600 share options exercised
Saisheng Pharmaceutical (06600) announced that on May 23, 2024, it will be granted under the initial public offering after-sales share purchase option plan...
Saisheng Pharmaceutical announced that the 44,500 share options granted have been exercised
Saisheng Pharmaceutical (06600) issued an announcement on May 22, 2024, according to the rules of the initial public offering after-sales share option plan: 7,500 share options granted under the initial public offering after-sales share option plan have expired; and the 44,500 share options granted under the initial public offering after-sales share option plan have been exercised.
Saisheng Pharmaceutical (06600): 44,500 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) issued an announcement on May 22, 2024, according to the rules of the initial public offering after-sales share option plan: 7,500 share options granted under the initial public offering after-sales share option plan have expired; and 44,500 share options granted under the initial public offering after-sales share option plan have been exercised.
Saisheng Pharmaceutical (06600): 40,000 share options have been exercised
According to the Zhitong Finance App, Saisheng Pharmaceutical (06600) announced that on May 20, 2024, the 40,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
A record high! The total number of clinical trials exceeded 4,000 in 2023
According to the report, in 2023, the total number of clinical trials registered on the drug clinical trial registration and information disclosure platform surpassed 4,000 for the first time, reaching 4,300 (in terms of CTR), the highest total number of registrations in history, an increase of 26.1% over the total number of registrations in 2022.
Saisheng Pharmaceutical announced that the 20,000 share options granted have been exercised
Saisheng Pharmaceutical (06600) announced that on May 16, 2024, 20,000 share options granted under the initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.
No Data